CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.
Leukemia, 32(4): 1049-1052 PMID 29209043 DOI 10.1038/leu.2017.346
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.
Leukemia, 32(4): 1049-1052 PMID 29209043 DOI 10.1038/leu.2017.346
This article has no abstract in PubMed.